Enhancement of CD8+ T cell responses by ICOS/B7h costimulation

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 132-139

  Wallin, J J ^a   Liang, L ^a   Bakardjiev, A ^a   Sha, W C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0035399581     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.132     Document Type: Article

References (31)

1. CD28 activation pathway regulates the production of multiple T cell-derived lymphokines/cytokines
2. CD28/B7 system of T cell costimulation
3. Co-stimulation in T cell responses
4. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
5. CTLA-4 can function as a negative regulator of T cell activation
6. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28
7. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα
8. T-cell co-stimulation through B7RP-1 and ICOS
9. Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor
10. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand
11. Characterization of human inducible costimulator ligand expression and function
12. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses
13. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity
14. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides
15. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens
16. + helper T cells
17. + T cells
18. + cytotoxic T lymphocytes in the absence of exogenous help
19. Immunization of the A/Jax mouse with irradiated cells of its indigenous tumour, sarcoma 1
20. GATA-3-dependent enhancer activity in IL-4 gene regulation
21. Protective antitumor immunity induced by immunization with MHC class II gene-transfected tumor cells is unrelated to MHC class II expression
22. Enhancement of antitumor immunity by CTLA-4 blockade
23. Manipulation of costimulatory signals to enhance antitumor T-cell responses
24. - tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice
25. Positive and negative selection of an antigen receptor on T cells in transgenic mice
26. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
27. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
28. + T cells by B7-transfected melanoma cells
29. + T cells
30. Differential transcription directed by discrete γ interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells
31. Inducible costimulator protein (ICOS) controls T helper subset polarization after virus and parasite infection